(Q39597656)

English

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines

scientific article published on 3 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

endometrial cancer

1 reference

based on heuristic

inferred from title

5

object named as

Ilan Bruchim

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Zohar Attias-Geva

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Itay Bentov

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ami Fishman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Haim Werner

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

3 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

383-389

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Papillary carcinomas of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

The insulin-like growth factor-I receptor as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Targeting the IGF1 axis in cancer proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Basic and clinical significance of IGF-I-induced signatures in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Endometrial cancer and the IGF system: a case-control study in Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.01.008

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39597656&oldid=1993583597"